170 related articles for article (PubMed ID: 11513040)
21. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
Benson CA; Segreti J; Beaudette FE; Hines DW; Goodman LJ; Kaplan RL; Trenholme GM
Antimicrob Agents Chemother; 1987 Feb; 31(2):328-30. PubMed ID: 2952063
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro study of novel 7-O-acyl derivatives of Oroxylin A as antibacterial agents.
Suresh Babu K; Hari Babu T; Srinivas PV; Sastry BS; Hara Kishore K; Murty US; Madhusudana Rao J
Bioorg Med Chem Lett; 2005 Sep; 15(17):3953-6. PubMed ID: 16046127
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antibacterial activity of 11,12-carbamate-3-O-acyl erythromycin derivatives.
Xu P; Liu L; He W; Li Y; Liu J; Lei PS
J Asian Nat Prod Res; 2009 Oct; 11(10):880-97. PubMed ID: 20183250
[TBL] [Abstract][Full Text] [Related]
25. Preparation and in vitro antibacterial activity of 9-O-glycosyloxime derivatives of erythromycin A, a new class of macrolide antibiotics.
Grandjean C; Lukacs G
J Antibiot (Tokyo); 1996 Oct; 49(10):1036-43. PubMed ID: 8968398
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.
Benson C; Segreti J; Kessler H; Hines D; Goodman L; Kaplan R; Trenholme G
Eur J Clin Microbiol; 1987 Apr; 6(2):173-8. PubMed ID: 2954818
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity against Gram-Negative Bacteria.
Cochrane SA; Li X; He S; Yu M; Wu M; Vederas JC
J Med Chem; 2015 Dec; 58(24):9779-85. PubMed ID: 26636619
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
Nam G; Kang TW; Shin JH; Choi KI
Bioorg Med Chem Lett; 2006 Feb; 16(3):569-72. PubMed ID: 16275089
[TBL] [Abstract][Full Text] [Related]
29. Erythromycin series. XII. Antibacterial in vitro evaluation of 10-dihydro-10-deoxo-11-azaerythromycin A: synthesis and structure-activity relationship of its acyl derivatives.
Djokić S; Kobrehel G; Lazarevski G
J Antibiot (Tokyo); 1987 Jul; 40(7):1006-15. PubMed ID: 3484349
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and in vitro activity of novel 2'-O-substituted 15-membered azalides.
Pešić D; Starčević K; Toplak A; Herreros E; Vidal J; Almela MJ; Jelić D; Alihodžić S; Spaventi R; Perić M
J Med Chem; 2012 Apr; 55(7):3216-27. PubMed ID: 22380766
[TBL] [Abstract][Full Text] [Related]
31. Synthetic studies of erythromycin derivatives. Synthesis and antimicrobial activities of 3''-EPI-erythromycin A and (9S)-11-dehydroxy-9-deoxo-9-hydroxy-11- oxoerythromycin A.
Nakata M; Tamai T; Miura Y; Kinoshita M; Tatsuta K
J Antibiot (Tokyo); 1993 May; 46(5):813-26. PubMed ID: 8514636
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives.
Zheng Z; Du D; Cao L; Liu J; Chen X
J Antibiot (Tokyo); 2016 Nov; 69(11):811-817. PubMed ID: 27118243
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antibacterial activity of 2-substituted 6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
Jung JC; Baek S; Park OS
Farmaco; 2001 Sep; 56(9):665-75. PubMed ID: 11680810
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological activity of novel antibacterial quinazolines.
Bedi PM; Kumar V; Mahajan MP
Bioorg Med Chem Lett; 2004 Oct; 14(20):5211-3. PubMed ID: 15380229
[TBL] [Abstract][Full Text] [Related]
35. 15-amido erythromycins: synthesis and in vitro activity of a new class of macrolide antibiotics.
Shaw SJ; Abbanat D; Ashley GW; Bush K; Foleno B; Macielag M; Zhang D; Myles DC
J Antibiot (Tokyo); 2005 Mar; 58(3):167-77. PubMed ID: 15895524
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of the properties of a drug by mono-deuteriation: reduction of acid-catalysed formation of a gut-motilide enol ether from 8-deuterio-erythromycin B.
Bhadra PK; Hassanzadeh A; Arsic B; Allison DG; Morris GA; Barber J
Org Biomol Chem; 2016 Jul; 14(26):6289-96. PubMed ID: 27273525
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivatives.
Clark RF; Ma Z; Wang S; Griesgraber G; Tufano M; Yong H; Li L; Zhang X; Nilius AM; Chu DT; Or YS
Bioorg Med Chem Lett; 2000 Apr; 10(8):815-9. PubMed ID: 10782693
[TBL] [Abstract][Full Text] [Related]
38. Isolation and structure of a new macrolide antibiotic, erythromycin G, and a related biosynthetic intermediate from a culture of Saccharopolyspora erythraea.
Cevallos A; Guerriero A
J Antibiot (Tokyo); 2003 Mar; 56(3):280-8. PubMed ID: 12760684
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem derivatives.
Oh CH; Dong HG; Lee JS; Lee SC; Hong JH; Cho JH
Arch Pharm (Weinheim); 2003 Dec; 336(12):567-72. PubMed ID: 14677150
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines.
Srinivas K; Srinivas U; Rao VJ; Bhanuprakash K; Kishore KH; Murty US
Bioorg Med Chem Lett; 2005 Feb; 15(4):1121-3. PubMed ID: 15686925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
